Nyxoah and Vanderbilt University Enter Exclusive Licensing Agreement Regarding Next Generation Neurostimulation Technologies to Treat Obstructive Sleep Apnea (OSA)

Mont-Saint-Guibert, Belgium, Feb. 2 (Korea Bizwire) – Nyxoah SA (Euronext: NYXH) (“Nyxoah” or the “Company”), a health-technology company focused on the development and commercialization of innovative solutions and services to treat Obstructive Sleep Apnea (OSA), today announces the Company has signed an exclusive license agreement with Vandebilt University, Nashville – TN, USA. The agreement allows Nyxoah to [...]